Clinical Trials Browser

Advanced Prostate Cancer × enzalutamide × 90 days × Clear all

NCT07198633 2026-06-02

A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer

Phase 1/2 Recruiting

Advanced Prostate Cancer